title: [PrEP approved in the USA: facts and discussion - permanent chemoprophylaxis for healthy people].
authors: Robert Koch-lnstitut, Abteilung Infektionsepidemiologie, Berlin. marcusU@rki.de
authors: Ulrich
authors: U
authors: Marcus
mesh_terms: D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017277:Drug Approval; D004338:Drug Combinations; D000069480:Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; D005260:Female; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission; D006801:Humans; D008297:Male; D009943:Organophosphorus Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D012307:Risk Factors; D012747:Sexual Partners; D047568:Unsafe Sex
chemical_list: D019380:Anti-HIV Agents; D004338:Drug Combinations; D000069480:Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; D009943:Organophosphorus Compounds; D003841:Deoxycytidine